Explore more publications!

Bay State Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bay State Times.

Press releases published on December 8, 2025

Jesus Barroso Highlights the Power of People-First Leadership at Build Safe Connection 2025
Spice Labs Announces  Post-Quantum Cryptography Inventory Builder
The Gnar Company Featured in AWS Transform Launch, Achieving 60-75% Efficiency Gains in Enterprise Modernization
Rony Jabour Inspires Massachusetts Construction Leaders With a High-Impact Speech at Build Safe Connection 2025
Dimensional Insight Recognized in KLAS 2025 Consistent High Performers Report
“LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Included in China’s Commercial Insurance Innovative Drug List
President’s Circle — A Distinction for Visionary Leaders
Imviva Biotech Presents Validating Data for CAR-T Cell Therapies CTD402 and CTA311 in Five Presentations at the 67th American Society of Hematology Annual Meeting
Imviva Biotech Presents Clinical Breakthroughs for CTD402 in High-Mortality T-Cell and Myeloid Leukemias at the 67th American Society of Hematology Annual Meeting
Massachusetts expanding ABA coverage to include children with Down syndrome
Veterans Healing Journey Becomes Soundtrack of Thrive Dispensaries
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
Fulcrum Therapeutics Announces Proposed $150.0 Million Public Offering of Common Stock
Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Kymera Therapeutics Announces Proposed Public Offering
Gordon Brothers Supports Advance Auto Parts with Non-Core Surplus Property Disposition Services
Build Safe Connection 2025 Sets a New Standard for Construction Leadership and Innovation in Massachusetts
Tiago Brunet Delivers a Powerful Speech in Boston at the Build Safe Connection 2025 Conference
Debut Romantasy Escala’s Wish Earns Early Acclaim Ahead of December Release
Cullinan Therapeutics Showcases Compelling Clinical Data in AML for CLN-049, Novel FLT3xCD3 T Cell Engager, in Oral Presentation at the 67th ASH Meeting

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions